Excellos: Funding, Investors & Team (Sep 2026)
Excellos is a company that designs and creates cell and gene therapies to promote the progress of advanced treatments. They specialize in CAR-T, tumor-infiltrating lymphocyte therapy, and immunotherapy, offering development and clinical manufacturing services. Their goal is to help clients utilize the potential of these potent therapeutics, ultimately saving patients' lives. Excellos focuses on providing cGMP cellular products and services, as well as process development and manufacturing expertise, to scientists and doctors working with cell and gene therapies. Their mission is to expedite the development of cellular therapies and maximize their effectiveness, resulting in saved lives and improved quality of life. They aim to establish a new standard of excellence in the industry.
Excellos has raised $5.0M across 1 funding round on record, the most recent an undisclosed round of $5.0M announced in Aug 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Excellos Company Profile and Key Stats
Latest funding round on record: Aug 2023.
Excellos Funding Rounds
Excellos Founders and Leadership Team
Contact details for the Excellos team: 1 of 1 has an email address on file.
Start 14-day free trial →Excellos Funding Compared to Other Biotechnology Startups
Excellos' latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Excellos in Biotechnology and San Diego
Companies Similar to Excellos
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Excellos Funding FAQs
What does Excellos do?
Excellos is a company that designs and creates cell and gene therapies to promote the progress of advanced treatments. They specialize in CAR-T, tumor-infiltrating lymphocyte therapy, and immunotherapy, offering development and clinical manufacturing services. Their goal is to help clients utilize the potential of these potent therapeutics, ultimately saving patients' lives. Excellos focuses on providing cGMP cellular products and services, as well as process development and manufacturing expertise, to scientists and doctors working with cell and gene therapies. Their mission is to expedite the development of cellular therapies and maximize their effectiveness, resulting in saved lives and improved quality of life. They aim to establish a new standard of excellence in the industry.
How much funding has Excellos raised?
Excellos has raised $5.0M across 1 round on record. The most recent is an undisclosed round of $5.0M announced in Aug 2023.
When did Excellos last raise funding?
Excellos' most recent funding round on record is an undisclosed round of $5.0M, announced in Aug 2023.
Who founded Excellos?
FundedIQ lists Robert Tressler (Founder) at Excellos.
Where is Excellos headquartered?
Excellos is based in San Diego, California, United States.
How many employees does Excellos have?
Excellos is in the 11-50 employee band.
How does Excellos' funding compare to other Biotechnology startups?
Excellos' latest round of $5.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Excellos Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Excellos is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.